Indication
Retinal Vein Occlusion
20 clinical trials
22 products
1 drug
Clinical trial
An Open-label, Single Group, Single-dose Clinical Study to Evaluate the Usability of the Pre-filled Syringe of SB11 in Subjects With Neovascular Age-Related Macular Degeneration or Macular Oedema Secondary to Retinal Vein OcclusionStatus: Completed, Estimated PCD: 2023-11-30
Product
SB11Clinical trial
A Pilot Study to Assess the Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumStatus: Not yet recruiting, Estimated PCD: 2024-07-01
Product
MB-102Product
Fluorescein sodiumProduct
MB-102 and Zeiss FF450Clinical trial
A Phase 1/1b Open Label, Multi-center Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With Wet Age-Related Macular Degeneration (wAMD), Diabetic Macular Edema (DME) and Retinal Vein Occlusion (RVO)Status: Terminated, Estimated PCD: 2021-06-02
Product
KSI-301Clinical trial
Open-label, Dose Ascending Safety, Tolerability, and Proof of Concept Study to Evaluate the Use of ANXV (Human Recombinant Annexin A5) in the Treatment of Subjects With Recently Diagnosed Retinal Vein OcclusionStatus: Recruiting, Estimated PCD: 2024-06-01
Product
ANXVClinical trial
Screening And Detecting Eye Diseases With Hybrid Deep Learning Algorithms From Fundus Images And Validation Of Automated Artificial Intelligence AlgorithmStatus: Recruiting, Estimated PCD: 2024-03-01
Product
Mydriatic AgentProduct
FaricimabProduct
AfliberceptClinical trial
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Branch Retinal Vein OcclusionStatus: Completed, Estimated PCD: 2022-07-06
Product
OZURDEXProduct
BrolucizumabClinical trial
A 12-month, Open-label, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of OZURDEX® Implant 700 µg (Dexamethasone) on Patients With Macular Edema Secondary to Retinal Vein Occlusion in China (YANGTZE Study)Status: Completed, Estimated PCD: 2021-09-26
Product
601Product
RanibizumabClinical trial
A Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of 601 Versus Ranibizumab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
An Eighteen-Month, Two-Arm, Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein OcclusionStatus: Terminated, Estimated PCD: 2021-07-26
Clinical trial
A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Two-arm, Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Visual Impairment Due to Treatment-naïve Macular Edema Secondary to Retinal Vein Occlusion (RVO)Status: Completed, Estimated PCD: 2022-06-20
Product
MHU650Clinical trial
A First-in-human, Open-label, Single Ascending Dose Study to Assess Safety and Tolerability of Intravitreal MHU650 in Participants With Macular Edema From Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (nAMD), or Retinal Vein Occlusion (RVO)Status: Completed, Estimated PCD: 2022-05-24
Product
Episcleral CelecoxibClinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Celecoxib Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Product
Episcleral DexamethasoneClinical trial
Phase I Study of Sequestered Transscleral, Controlled-Release Dexamethasone Delivered Via Episcleral Reservoir for Treatment of Macular Edema & Inflammatory Disorders of the Eye Posterior Pole Including Sclera, Choroid, Retina or VitreousStatus: Active (not recruiting), Estimated PCD: 2024-09-30
Clinical trial
Correlation of Vascular Endothelial Growth Factor Levels in Anterior Chamber Fluid to Disease State in Patients With Retinal Vein Occlusion Receiving Standard of Care TreatmentStatus: Terminated, Estimated PCD: 2023-12-18
Clinical trial
China Faricimab Real World Evidence: Evaluation of Faricimab Effectiveness, Safety and Treatment Pattern, in Diabetic Macular Edema, Retinal Vein Occlusion and Neovascular Age-Related Macular Degeneration: The Farseeing StudyStatus: Recruiting, Estimated PCD: 2027-11-30
Clinical trial
A Pilot Clinical Trial of the Feasibility and Safety of Intravitreal Autologous Adult Bone Marrow Stem Cells in Treating Eyes With Vision Loss From RetinopathyStatus: Active (not recruiting), Estimated PCD: 2025-10-01
Product
CD34+ Bone Marrow Stem CellsClinical trial
Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein OcclusionStatus: Completed, Estimated PCD: 2022-07-20
Clinical trial
Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein OcclusionStatus: Recruiting, Estimated PCD: 2024-10-30
Clinical trial
Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein OcclusionStatus: Completed, Estimated PCD: 2020-12-31
Product
EYLEAClinical trial
Near-Infrared Fluorescence Molecular Imaging of ANXV-800CW to Visualize Its Biodistribution in the Eyes of Patients Suffering From Retinal Vein OcclusionStatus: Recruiting, Estimated PCD: 2024-01-01
Drug
Annexin A5